Ossicodone Aurobindo (Oxycodone Hydrochloride)

Ossicodone Aurobindo is an opioid analgesic that acts on the central nervous system to relieve pain.

• Acute postoperative pain: provides effective relief after surgical procedures.
• Cancer‑related pain: helps control moderate to severe pain associated with malignancies.
• Chronic non‑cancer pain: used when other analgesics are inadequate for persistent pain conditions.

• Oxycodone hydrochloride binds primarily to μ‑opioid receptors in the central nervous system, activating inhibitory G‑protein pathways that reduce neuronal excitability and diminish the perception of pain. This receptor activation also modulates neurotransmitter release, contributing to its analgesic effect.

Ossicodone Aurobindo may cause a range of adverse reactions, from mild to severe.

Common Side Effects

• Constipation: reduced gastrointestinal motility.
• Nausea: feeling of queasiness, sometimes with vomiting.
• Drowsiness: increased sleepiness or fatigue.
• Dizziness: light‑headed sensation, especially when standing.
• Dry mouth: reduced salivary flow.
• Pruritus: mild skin itching.

Serious or Rare Side Effects

• Respiratory depression: slowed or shallow breathing that can be life‑threatening.
• Severe hypotension: marked drop in blood pressure.
• Opioid use disorder: dependence or addiction potential.
• Seizures: rare occurrence of convulsive episodes.
• Anaphylaxis: acute allergic reaction with rash, swelling, and airway compromise.
• adrenal insufficiency: rare hormonal imbalance affecting stress response.

When prescribing Ossicodone Aurobindo, clinicians should consider several safety measures.

• Assess pain severity and prior opioid exposure: determine suitability before initiating therapy.
• Monitor for respiratory depression: especially during dose titration and in opioid‑naïve patients.
• Evaluate renal and hepatic function: adjust dosing in impairment.
• Avoid concomitant CNS depressants: limit use with benzodiazepines or alcohol.
• Educate patients on constipation management: use laxatives or stool softeners as needed.
• Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Ossicodone Aurobindo can interact with several medication classes, requiring careful management.

Major Interactions (Avoid)

• Benzodiazepines: combined use may cause profound respiratory depression.
• Central nervous system depressants: additive sedation and decreased alertness.
• MAO inhibitors: risk of hypertensive crisis or serotonin syndrome.

Moderate Interactions (Monitor Closely)

• CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may increase oxycodine  
• CYP3A4 inducers: increase metabolism, potentially reducing analgesic effect.
• Anticholinergic agents: may exacerbate constipation.
• Diuret‑tous‑  

-